Skip to content

Effect of metamizole on CYP2B6 enzyme activity and its relationship with CYP2B6 genotype

Effect of metamizole on CYP2B6 enzyme activity and its relationship with CYP2B6 genotype

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-TNRC-10001118
Enrollment
Unknown
Registered
2010-11-08
Start date
2008-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

CYP2B6*6/*6:CYP2B6*6/*6
CYP2B6*1/*1:CYP2B6*1/*1
CYP2B6*1/*6:CYP2B6*1/*6

Sponsors

Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 23 Years

Inclusion criteria

Inclusion criteria: 1. Male 18 years old and over; 2. The subjects were ascertained to be in good health by medical history, a full clinical examination, and standard hematologic and blood chemistry laboratory tests before enrollment; 3. The subjects were not taking any regular medication and were asked to refrain from consuming alcohol, grapefruit juice, coffee, green tea, any vitamins and nutritional supplements for 2 weeks before study commencement and throughout the study.

Exclusion criteria

Exclusion criteria: 1. Check the indicators are not normal; 2. smokers or drinkers; 3. taking other drugs in two weeks.

Design outcomes

Primary

MeasureTime frame
Bupropion AUC0-infinity;Bupropion AUC0-48;

Countries

China

Contacts

Public ContactLan Fan
fanlan_038038@163.com+86 0731 84805380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026